中国留学生入境洛杉矶被盘问 行李中多件衣服丢失




中国留学生入境洛杉矶被盘问 行李中多件衣服丢失

中国新闻网

10/12/2021

  中新网10月12日电 据美国《世界日报》报道,近来传出不少中国留学生在入境美国时遭恐吓、盘问等事件。而有一名从洛杉矶入境的中国留学生表示,自己被短暂盘问后,竟还发现行李中的一些衣物被拿走了。目前他不能确定这是机场或是航空公司人员,还是海关人员拿走的。

  中国驻洛杉矶总领事馆近日表示,有多名中国留学生入境美国时,被边境执法人员反复盘查询问赴美求学目的。部分学生被恐吓、威胁,甚至被限制自由达数十小时,最后被遣返。

  不过从洛杉矶国际机场入境,前往圣地牙哥念书的留学生T同学的遭遇,令他匪夷所思。T同学大约在两周前入境,因为最近疫情管控,普通民众难以出入境,因此当时航班上几乎全是留学生。当时他在通过入境官窗口时,官员问了他一些正常都会问的问题,便叫他在一边等待。



  T同学表示,等待区域并非“小黑屋”,而就是在一排窗口的边上。当时有好几个留学生也被叫到那里一起等,几人互相问候后发现,都是从一个学校转学去另一个学校的学生。T同学表示,当时等了至少一个多小时后,才将他们叫到窗口前,重新问了一大堆常规问题。T同学学习的是艺术类专业,海关官员倒也并没有问特别的问题,问完也就将他放走了。

  随后,T同学前往领取行李的区域,由于等待太久,几人的行李已经被放到一边。当时T同学发现行李被打开,留了一张纸条称因为有人的酒水打翻,因此行李可能被酒浸染,并表示若有问题可以拨打一个电话号码。T同学表示,当时他大致看了一下,觉得只有一条裤子被洒上一点点酒,觉得没什么大问题,于是便没在意,纸条也丢失了。

  由于最近学校附近租房难找,T同学又在朋友家借宿几天,直到上周才真正将所有行李打开一一整理,便发现不少衣服都不见了。他表示,丢失的衣物大多是还没有剪掉标牌的T恤,不过也有几件剪掉标牌的衣服被拿走。T同学生气怀疑是海关人员拿走的,不过他也无法排除是否是机场人员或是航空公司人员所为。甚至也可能是因为长时间放在行李区一旁无人看管,被人偷拿。虽然他被海关扣押时间并不长,但他相信后续取行李等可能的困难,确实会给留学生带来麻烦。

Source


This image has an empty alt attribute; its file name is Winnie-Wang-最佳房地产经纪人-04252021-RED-1024x1024.jpg
Fang (Winnie) Schreck | United Real Estate
Tel: 551-580-4856 | Email: F.WINNIE.S@GMAIL.COM

诚招美国和加拿大法律服务代理

因公司发展需要,诚招美国和加拿大法律服务代理。

要求:

懂英语、或西班牙语、或法语。

能合法工作有社安号或工号。

无需改行, 可以兼职。

大学生和有销售经验优先考虑。

自雇生意公司发美国报税1099,加拿大T4A

有意了解详情, 请扫码加微信, 非诚勿扰!



中国驻洛杉矶总领馆:多名留学生入境美国时遭盘查恐吓遣返

10/10/2021

中国驻洛杉矶总领事馆当地时间8日在其官方网站发布提醒,自洛杉矶出入境的中国留学生注意安全风险。

中国驻洛杉矶总领馆称,近期,多名中国留学生在洛杉矶国际机场入境时,遭美国边检执法人员反复盘问来美学习目的、过往学业成绩、是否曾经就业、是否受过纪律处分、是否“剽窃”实验室数据等情况,有的还遭到威胁、恐吓,甚至被限制自由长达数十小时,最终被拒绝入境遣返回国。

中领馆称,此外,还有部分中国留学生离境回国时遭美执法人员盘查,被没收个人电子设备。领馆已就此向美方提出严正交涉,敦促美方纠正错误,停止利用各种借口对中国留学生进行无端限制和打压。

领馆提醒出国留学人员提高安全意识,关注出入境时可能遇到的风险,加强防范,妥善应对。

Source 



中国驻洛杉矶总领事馆

提醒:自洛杉矶出入境的中国留学生注意安全风险

2021/10/08 

  近期,多名中国留学生在洛杉矶国际机场入境时,遭美国边检执法人员反复盘问来美学习目的、过往学业成绩、是否曾经就业、是否受过纪律处分、是否“剽窃”实验室数据等情况,有的还遭到威胁、恐吓,甚至被限制自由长达数十小时,最终被拒绝入境遣返回国。此外,还有部分中国留学生离境回国时遭美执法人员盘查,被没收个人电子设备。我馆已就此向美方提出严正交涉,敦促美方纠正错误,停止利用各种借口对中国留学生进行无端限制和打压。  

  驻洛杉矶总领馆提醒出国留学人员提高安全意识,关注出入境时可能遇到的风险,加强防范,妥善应对。自洛杉矶出入境的中国留学生如遇紧急情况,请及时联系驻洛杉矶总领馆寻求协助。  

  驻洛杉矶总领馆领保热线:+1-213-8078052。  

  外交部全球领事保护与服务应急热线(24小时):+86-10-12308或+86-10-59913991。  

Source



中华人民共和国驻美利坚合众国大使馆

郑重提醒在美中国公民加强安全防范 警惕针对亚裔的歧视和暴力

2021/08/28

  8月27日,美国国家情报总监办公室发布所谓“新冠病毒溯源调查报告”要点,认为目前新冠病毒源自自然界和实验室泄漏的两种可能性都不能排除。报告诬蔑中方阻挠国际调查、拒绝共享信息并指责他国。白宫同日就新冠病毒溯源调查发布声明,妄称中方阻挠溯源工作的国际调查,缺乏透明度,企图纠集有关伙伴方对中方施压。中方对此坚决反对、强烈谴责。

  美国政府通过情报机构搞所谓溯源报告,妄图对中国进行“有罪推定”,是为了推卸自身抗疫失败责任、向中国甩锅推责。美方这种做法只会对国际溯源和全球抗疫合作造成干扰和破坏,对美民众形成不良引导,引发新一轮针对亚裔的歧视和暴力。

  中国驻美使馆郑重提醒广大在美中国公民务必加强安全防范,警惕针对亚裔的歧视和暴力。遭遇此类情况务必保持冷静,妥善应对,尽量避免发生口角和肢体冲突,确保自身安全。如遇暴力行为和安全威胁,请立即拨打美国报警、求助电话:911(可要求中文服务),或请求他人协助报警,并及时向校方、雇佣方反映和寻求帮助,要求依法依规公正处理。必要时,可循法律途径维护自身合法权益。

  如涉及领事协助,可联系外交部全球领事保护与服务应急热线或相应使领馆领事保护与协助电话。

  外交部全球领事保护与服务应急热线(24小时):+86-10-12308或+86-10-59913991

  中国驻美国使领馆领事保护与协助电话:

  驻美国使馆:+1-202-4952216

  驻纽约总领馆:+1-212-6953125

  驻旧金山总领馆:+1-415-2168525

  驻洛杉矶总领馆:+1-213-8078052

  驻芝加哥总领馆:+1-312-7800170

原文



中国驻美使馆提醒公民警惕“仇亚”暴力

8/28/2021

针对美国国家情报总监办公室发布的“新冠病毒溯源调查报告”,中国驻美国使馆提醒中国公民加强安全防范警惕“仇亚”暴力。

中国驻美国大使馆网站发布的公告称,美国国家情报总监办公室发布“新冠病毒溯源调查报告”认为目前冠病病毒源自自然界和实验室泄漏的两种可能性都不能排除,并指中方阻挠国际调查、拒绝共享信息并指责他国,中方对此坚决反对、强烈谴责。



公告说,美国政府通过情报机构搞溯源报告,妄图对中国进行“有罪推定”,是为了推卸自身抗疫失败责任、向中国甩锅推责。美方这种做法只会对国际溯源和全球抗疫合作造成干扰和破坏,对美民众形成不良引导,引发新一轮针对亚裔的歧视和暴力。

公告就此郑重提醒广大在美中国公民务必加强安全防范,警惕针对亚裔的歧视和暴力。遭遇此类情况务必保持冷静,妥善应对,尽量避免发生口角和肢体冲突,确保自身安全。如遇暴力行为和安全威胁,立即拨打美国报警、求助电话或请求他人协助报警,并及时向校方、雇佣方反映和寻求帮助,要求依法依规公正处理。必要时,可循法律途径维护自身合法权益。​​​​

Source



美情报部门公布新冠病毒溯源报告非机密评估摘要:不确定病毒来源

据央视新闻消息,当地时间8月27日,美国国家情报总监办公室公布了新冠病毒溯源报告非机密评估摘要,称情报系统各分支在新冠起源的两种主流观点——“实验室泄漏说”和“自然起源说”之间仍无法统一观点。

报告没有对新冠病毒起源给出定论,不过,报告指出,调查结果表明新冠病毒并非是作为生物武器创造而来。同时,新冠病毒也几乎不可能是通过基因工程编辑而来。同时,报告称,中国官员在新冠疫情暴发前并没有对这种病毒有所了解。此前,美国总统拜登曾命令情报部门对新冠病毒起源发起调查,并限时90天给出调查报告。

Source



证据来了!美专家是“合成冠状病毒第一人”

来源:新华社

8/20/2021

8月11日,一名行人经过美国纽约一处提供新冠疫苗接种的药店。
新华社记者 王迎 摄

新冠疫情暴发以来,美国一些政客炮制新冠病毒“实验室泄漏论”“实验室合成论”。如果真相信这些阴谋论,美国应该首先“自查”,因为多项科研成果和专利信息显示,美国专家拉尔夫·巴里克是“合成冠状病毒第一人”。

现年67岁的巴里克是美国北卡罗来纳大学教堂山分校病毒学和传染病学教授,在冠状病毒领域已深耕30多年,并有自己的实验室。

早在2003年,“非典”(SARS)疫情暴发后不久,巴里克就克隆了具有传染性的SARS病毒毒株。北卡罗来纳大学校刊《奋进者》2003年秋季号报道说,巴里克当时是在马里兰州的“美国陆军顶级BSL3实验室”,即德特里克堡生物实验室完成了这次实验。校刊还说,巴里克是“唯一能克隆所有冠状病毒的美国研究人员”。



8月11日,人们走在美国纽约宾夕法尼亚车站的新乘车大厅内。
新华社记者 王迎 摄

2004年,巴里克团队开始“SARS病毒逆向遗传学”研究,并连续多年获得美国国家卫生研究院基金资助。项目介绍上说:“我们是美国唯一能成功组装SARS病毒、鼠肝炎病毒和猪传染性肠胃炎病毒的全序列互补DNA(cDNA)的研究团队。”这项研究分三步:第一是制作SARS病毒的全序列互补DNA克隆,第二步是用这个互补DNA克隆来合成SARS病毒,第三步是用鼠细胞验证这样制作的SARS病毒的传染性。互补DNA特指在体外经过逆转录后与RNA互补的DNA链,可作为合成冠状病毒等RNA病毒的“中介”。


Six Spaces Home Staging

This image has an empty alt attribute; its file name is Six-Spaces-Home-Staging.jpg
Fairfax, VA
Contact: Hongliang Zhang
Tel: 571-474-8885
Email: zhl19740122@gmail.com

2008年11月25日,巴里克团队在美国《国家科学院学报》网络版发表论文《合成重组的SARS样冠状病毒对培养细胞和实验鼠具有传染性》,宣布这次研究成功。有媒体称,这是全球首次在实验室人工合成SARS病毒。

下一步,巴里克团队开始尝试“杂交”不同的冠状病毒。2015年11月,巴里克团队在《自然·医学》杂志发表论文说,他们成功制作了一种“嵌合体”病毒,拥有一种蝙蝠冠状病毒的刺突蛋白和另一种冠状病毒的骨干,这种“嵌合体”病毒对人类细胞有传染性。

记者查阅美国专利局网站发现,巴里克团队拥有与合成病毒相关的多项专利。比如,一项编号为7279327的专利于2002年4月申请,2007年10月获批,名为“制作重组冠状病毒的方法”。巴里克曾在多个场合承认,他的团队掌握了合成多种冠状病毒的独家技术。

原文链接>>



US virologists synthesize infectious SARS-like coronavirus in 2008: PNAS

Xinhua

8/20/2021

BEIJING — A group of US virologists reported “the design, synthesis, and recovery of the largest synthetic replicating life form,” a 29.7-kb bat SARS-like coronavirus in an article published in the US scientific journal PNAS as early as October 2008.

The article reported the creation in laboratory of the coronavirus, which was not only infectious in mice, but also in human airway epithelial cell cultures.

Researchers have the ability to design and synthesize various SARS-like coronaviruses, said Ralph Baric, professor at the University of North Carolina and leading author of the article published in the scientific journal PNAS.



Since 1983, Baric has published over 400 papers in his own name or as an instructor, including 268 papers on coronavirus. He has been exploring the analysis, manipulation and creation of coronavirus, and recombining, cloning, modifying and transforming different viruses for more than 30 years, according to a report by China’s Science and Technology Daily on Thursday.

Insufficient fund had been the biggest headache of Baric in his study of coronavirus until the outbreak of SARS in 2003, which proved to the world the lethality of coronavirus and the tremendous damage coronavirus could inflict on humanity.

In 2006, after an unknown number of generations of targeted culture of viruses by Baric’s team, a mutation that can successfully cause rapid death in mice appeared, and this new virus can infect humans and lead to pneumonia and higher mortality.



In a report, he warned that the technology of synthesizing virus sequences has the potential to be used to make biological weapons of mass destruction. However, his warning was seen as an advertisement by warmongers.

The Fort Detrick lab researchers were among the inventors of many of Baric’s granted patents. This practice is more conducive to covert patent sharing, so that the staff of the lab will no longer have to pay patent fees for virus preparation in the future.

The article described Baric’s creation of coronavirus with an aim to respond to health emergencies as “confusing.”

Source



CDC

Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

Media Statement

For Immediate Release: Wednesday, August 18, 2021
Contact: Media Relations
(404) 639-3286

Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people.

The statement is attributable to Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC); Dr. Janet Woodcock, Acting Commissioner, Food and Drug Administration (FDA); Dr. Vivek Murthy, U.S. Surgeon General; Dr. Francis Collins, Director of the National Institutes of Health (NIH); Dr. Anthony Fauci, Chief Medical Advisor to President Joe Biden and Director of the National Institute of Allergy and Infectious Diseases (NIAID); Dr. Rachel Levine, Assistant Secretary for Health; Dr. David Kessler, Chief Science Officer for the COVID-19 Response; and Dr. Marcella Nunez-Smith, Chair of the COVID-19 Health Equity Task Force:



“The COVID-19 vaccines authorized in the United States continue to be remarkably effective in reducing risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant. Recognizing that many vaccines are associated with a reduction in protection over time, and acknowledging that additional vaccine doses could be needed to provide long lasting protection, we have been analyzing the scientific data closely from the United States and around the world to understand how long this protection will last and how we might maximize this protection. The available data make very clear that protection against SARS-CoV-2 infection begins to decrease over time following the initial doses of vaccination, and in association with the dominance of the Delta variant, we are starting to see evidence of reduced protection against mild and moderate disease. Based on our latest assessment, the current protection against severe disease, hospitalization, and death could diminish in the months ahead, especially among those who are at higher risk or were vaccinated during the earlier phases of the vaccination rollout. For that reason, we conclude that a booster shot will be needed to maximize vaccine-induced protection and prolong its durability.



“We have developed a plan to begin offering these booster shots this fall subject to FDA conducting an independent evaluation and determination of the safety and effectiveness of a third dose of the Pfizer and Moderna mRNA vaccines and CDC’s Advisory Committee on Immunization Practices (ACIP) issuing booster dose recommendations based on a thorough review of the evidence. We are prepared to offer booster shots for all Americans beginning the week of September 20 and starting 8 months after an individual’s second dose. At that time, the individuals who were fully vaccinated earliest in the vaccination rollout, including many health care providers, nursing home residents, and other seniors, will likely be eligible for a booster. We would also begin efforts to deliver booster shots directly to residents of long-term care facilities at that time, given the distribution of vaccines to this population early in the vaccine rollout and the continued increased risk that COVID-19 poses to them.

“We also anticipate booster shots will likely be needed for people who received the Johnson & Johnson (J&J) vaccine. Administration of the J&J vaccine did not begin in the U.S. until March 2021, and we expect more data on J&J in the next few weeks. With those data in hand, we will keep the public informed with a timely plan for J&J booster shots as well.



“Our top priority remains staying ahead of the virus and protecting the American people from COVID-19 with safe, effective, and long-lasting vaccines especially in the context of a constantly changing virus and epidemiologic landscape. We will continue to follow the science on a daily basis, and we are prepared to modify this plan should new data emerge that requires it.

“We also want to emphasize the ongoing urgency of vaccinating the unvaccinated in the U.S. and around the world. Nearly all the cases of severe disease, hospitalization, and death continue to occur among those not yet vaccinated at all. We will continue to ramp up efforts to increase vaccinations here at home and to ensure people have accurate information about vaccines from trusted sources. We will also continue to expand our efforts to increase the supply of vaccines for other countries, building further on the more than 600 million doses we have already committed to donate globally.”

Source


Russian School of Mathematics